Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) EBT: 2012-2024

Historic EBT for Neurogene (NGNE) over the last 11 years, with Dec 2024 value amounting to -$75.7 million.

  • Neurogene's EBT fell 3.65% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 23.93%. This contributed to the annual value of -$75.7 million for FY2024, which is 43.76% down from last year.
  • According to the latest figures from FY2024, Neurogene's EBT is -$75.7 million, which was down 43.76% from -$52.7 million recorded in FY2023.
  • Over the past 5 years, Neurogene's EBT peaked at -$52.7 million during FY2023, and registered a low of -$75.7 million during FY2024.
  • For the 3-year period, Neurogene's EBT averaged around -$61.2 million, with its median value being -$55.2 million (2022).
  • Per our database at Business Quant, Neurogene's EBT rose by 4.58% in 2023 and then tumbled by 43.76% in 2024.
  • Neurogene's EBT (Yearly) stood at -$55.2 million in 2022, then increased by 4.58% to -$52.7 million in 2023, then plummeted by 43.76% to -$75.7 million in 2024.